Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

4th International Conference on Lymphocyte Engineering, gathered together the world’s innovators in immune-gene therapy in Munich, Germany on 12-14 September 2023. Professor Natalia Marek-Trzonkowska form ICCVS took part in this interesting scientific event. She had great opportunity to refresh friendships and cooperation networks. With Anke Fuchs (Technical University of Dresden) and Marc Martinez- Llordella (Quell Therapeutics)- three members of the “Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies” (COST Action). To learn more about the conference please go here.